Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

247.02 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Full Transcript: Johnson & Johnson Q2 2026 Earnings Call ↗
Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
News headline image
Is Johnson & Johnson a Buy After Its Latest Earnings Report? ↗
Investors didn't seem to think so after the company published it. 
Via The Motley Fool
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity ↗
Johnson & Johnson's post-earnings pullback follows a revenue and EPS beat, raised guidance, and analyst price target increases, with talc litigation remaining the key risk to watch. 
Via MarketBeat
Topics Intellectual Property
Johnson & Johnson (NYSE:JNJ) Raises Full-Year Guidance After In-Line Q2 Results ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
News headline image
Johnson & Johnson Q2 Earnings Call Highlights ↗
Johnson & Johnson (NYSE:JNJ) raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches... 
Via MarketBeat
Topics ETFs Earnings
News headline image
Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook ↗
Johnson & Johnson beats Q2 2026 Wall Street estimates and raises full-year guidance as sales top $25B, driven by oncology and MedTech. 
Via Benzinga
News headline image
Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday ↗
Morgan Stanley, Pentair, Johnson & Johnson expected to release earnings, ASML posts strong results, Progressive to report 
Via Benzinga
Top dow jones movers in Tuesday's session ↗
Via Chartmill
News headline image
Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways’ ↗
Johnson & Johnson stock trades near all-time highs. A strong Q2 report and the chart show more upside ahead. 
Via Benzinga
News headline image
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings ↗
Earnings report for JNJ expected on July 15, with analysts predicting $2.85/share & $25.06B revenue. Stock price target raised to $287/share. 
Via Benzinga
News headline image
This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy? ↗
The dividend looks secure. The share price is the harder call. 
Via The Motley Fool
Topics Lawsuit
News headline image
Stock Indexes Split as Chip Stocks Fall, Oil Surges ↗
Why are chip stocks collapsing while the Dow barely budges? Korean markets just had their worst day since the 2008 financial crisis, and the fallout is hitting semiconductors hard. 
Via The Motley Fool
Topics Artificial Intelligence Government Initial Public Offering
News headline image
3 Dividend Stocks Leading 2026's Rotation Into Value ↗
As investors flee this year's high flyers, a few dependable payers are catching the money. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors. ↗
Griffin is at the helm of the world's most profitable hedge fund. 
Via The Motley Fool
News headline image
This Dividend ETF Choice Could Shape Your Income Strategy Through 2026 ↗
VYM and SCHD both offer low-cost dividend exposure, but differ in methodology, yield, and holdings—VYM emphasizes broad, higher-yield diversification, while SCHD focuses on stricter, dividend-growth... 
Via MarketBeat
Topics Bonds ETFs Economy
News headline image
Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗
There are good reasons to invest in Lilly and to hold off. 
Via The Motley Fool
News headline image
History Says Doing This 1 Thing Will Score You an Investing Win -- Even After a Market Crash. ↗
It's something very simple. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
Top dow jones movers in Friday's session ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Top dow jones movers in Thursday's session ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger ↗
As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities. 
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026 ↗
Kimberly-Clark is far from flashy, but what it lacks in glitz and glam, it makes up for with predictability. 
Via The Motley Fool
Topics Earnings Economy Stocks
News headline image
2 Dividend Kings to Buy and Hold Forever ↗
These stocks have long histories of growing their payouts to shareholders. 
Via The Motley Fool
Topics Economy
News headline image
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now ↗
They may not remain cheap for too much longer. 
Via The Motley Fool
Topics Intellectual Property
News headline image
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend ↗
Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks. 
Via The Motley Fool
News headline image
5 Dividend Kings Long-Term Investors Should Own for the Next 20 Years ↗
Investors can count on these stocks about as much as any to continue their decades-long runs of excellence. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.